Ranbaxy Stability Testing System Draws FDA GMP Warning Letter

An FDA analysis of isotretinoin samples following a February inspection finds “lower potencies in these batches” before their expiration dates.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet